Daily as of 3 Nov 16:00 ET
- Price
- below both $20.35 vs 50 $32.29 / 200 $48.40
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 💀Death cross 26 May 2026 · projected 29 bars out
GPCR | Structure TherapeuticsNASDAQHealthcareADR golden cross and death cross projections, cross tests and history
$20.35
-$0.12 (-0.59%)
Structure Therapeutics (GPCR) is a NASDAQ-listed ADR that Cruxta has tracked for 50/200 crosses since 2023.
The 50 SMA has sat below the 200 on the daily since May 2026, with no cross projected inside the 30 bars Cruxta tracks. Price sits below the 50 and the 200 on the daily and the 4-hour.
Timeframe summary
Weekly
No weekly data
4-hour as of 3 Nov 16:00 ET
- Price
- below both $20.35 vs 50 $23.75 / 200 $41.23
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 💀Death cross 21 Sep 2026 · projected 28 bars out
Cross history
| Crossed | Direction | Timeframe | Projected | Cross test |
|---|---|---|---|---|
| 21 Sep 2026 | 💀Death | 4-hour | 28 bars out | Not tested |
| 15 Jul 2026 | 🟨Golden | 4-hour | 27 bars out | 7 bar cross test |
| 26 May 2026 | 💀Death steep | daily | 29 bars out | Not tested |
| 24 Mar 2026 | 💀Death | 4-hour | 30 bars out | Not tested |
| 16 Oct 2025 | 🟨Golden steep | daily | 26 bars out | Not tested |
About GPCR
ExchangeNASDAQ
InstrumentADR
Median $ volume, 60 d$34.5M
4-hour coverageYes, since Oct 2025
History on recordSince 2023
SectorHealthcare
Cap bandmid